Stay updated on Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page.

Latest updates to the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4. This appears to be an administrative version update rather than a change to the study content.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision: v3.5.3 was added and the previous 'Revision: v3.5.2' was removed, signaling a minor platform update. This is a versioning change rather than a modification to study content or results.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No visible changes to study details or page content.SummaryDifference0.0%

- Check59 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 on the page.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3; no visible changes to study content or navigation.SummaryDifference0.0%

- Check95 days agoChange DetectedAdded site revision tag v3.4.2; removed the government funding operating-status notice, and these changes do not affect the study details or eligibility information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page.